Abstract
Adequate zinc nutriture is necessary for normal bone growth and development, though the precise mechanisms for zinc-mediated bone growth remain poorly defined. A key transcription factor activated by zinc is metal response element-binding transcription factor 1 (MTF-1), which binds to the metal regulatory element (MRE). We hypothesize that MREs will be found upstream of miRNA genes as well as miRNA target genes in the following bone growth and development signaling pathways: TGF-β, MAPK, and Wnt. A Bioconductor-based workflow in R was designed to identify interactions between MREs, miRNAs, and target genes. MRE sequences were found upstream from 64 mature miRNAs that interact with 213 genes which have MRE sequences in their own promoter regions. MAPK1 exhibited the most miRNA–target interactions (MTIs) in the TGF-β and MAPK signaling pathways; CCND2 exhibited the most interactions in the Wnt signaling pathway. Hsa-miR-124-3p exhibited the most MTIs in the TGF-β and MAPK signaling pathways; hsa-miR-20b-5p exhibited the most MTIs in the Wnt signaling pathway. MYC and hsa-miR-34a-5p were shared between all three signaling pathways, also forming an MTI unit. JUN exhibited the most protein–protein interactions, followed by MAPK8. These in silico data support the hypothesis that intracellular zinc status plays a role in osteogenesis through the transcriptional regulation of miRNA genes via the zinc/MTF-1/MRE complex.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Zinc (Zn) is an essential trace element involved in fundamental biochemical and physiological pathways. It is necessary for enzyme catalysis, protein structure, and various regulatory functions as approximately 2800 enzymes and proteins bind Zn (10% of the human genome) (Andreini et al. 2006), and approximately 3% of our genome encodes zinc finger transcription factors (Klug 2010). Approximately 4% of the worldwide population is Zn deficient (Wuehler et al. 2005), and children are the most affected (Hambidge and Krebs 2007; Tuerk and Fazel 2009). Proper Zn nutriture is necessary for normal growth and development in animals and humans. Consumption of a Zn-depleted diet resulted in reduced bone Zn and growth in rodent animal models (Chu et al. 2003; Grider et al. 2007; Keller et al. 2000). Manipulation of the Zn nutritional environment affects osteogenic biomarkers (Berger et al. 2015; Cho et al. 2007; Seo et al. 2010). Current recommendations for assessing the risk of Zn deficiency in populations includes the functional assessment of length- or height-for-age measurements (Hess et al. 2009; International Zinc Nutrition Consultative Group et al. 2004).
The molecular mechanisms associated with the effect of Zn on bone growth and metabolism are the focus of ongoing research. Circulating levels of insulin-like growth factor-1 (IGF-1) correlate with dietary Zn levels and Zn status in children in some studies (Bougle et al. 2004; Cesur et al. 2009; Hamza et al. 2012; Imamoglu et al. 2005) but not others (Park et al. 2017). Zn supplementation increases the synthesis of IGF-1 in bone (Igarashi and Yamaguchi 2001) and the binding of IGF-1 to its receptor (McCusker 1998; McCusker et al. 1998; Sackett and McCusker 1998a; Sackett and McCusker 1998b). Signaling pathways that are also involved with bone formation include transforming growth factor β/bone morphogenic protein (TGF-β/BMP), wingless-type (Wnt), p38 mitogen-activated protein kinase (MAPK), Hedgehog, Notch, and fibroblast growth factor (FGF). Significant cross-talk occurs between these pathways (Chen et al. 2012). The TGF-β/BMP, Wnt, MAPK, and Hedgehog pathways also intersect with the IGF-1 pathway (Guntur and Rosen 2013; Longobardi et al. 2006; Tahimic et al. 2013).
We hypothesize that the Zn-dependent regulation of bone growth and development involves microRNAs (miRNAs) and metal regulatory elements (MREs), ultimately forming complex and precise regulatory cascades of gene expression (Arora et al. 2013). MiRNAs are small, noncoding RNAs involved in the posttranslational regulation of gene expression through binding to seed sequences in the 3′ untranslated regions (UTR) of mRNA, resulting in transcriptional repression (Lee et al. 1993), or in the 5′ terminal oligopyrimidine tracts of ribosomal protein mRNA, resulting in translational activation (Orom et al. 2008). MiRNAs have also been shown to form complexes with certain regulatory proteins resulting in translational activation (Eiring et al. 2010; Vasudevan et al. 2007). The MRE is a conserved 7-base motif (5′-TGCRCNC-3′; R = A or G, N = any nucleotide) that is bound by metal transcription factor-1 (MTF-1), a 72.5 kDa Zn-finger (ZF) protein in the Cys2His2 family of transcription factors (Stuart et al. 1984; Langmade et al. 2000; O’Halloran 1993; Saydam et al. 2002). MTF-1 contains six ZFs and exhibits Zn-dependent binding to the MRE, with ZF1 and possibly ZF3 and ZF6 responsible for its Zn-sensing and MRE binding properties (Bittel et al. 2000; Chen et al. 1999; Chen et al. 1998; Guerrerio and Berg 2004).
Results from in vivo and in vitro studies indicate Zn-dependent differential miRNA expression (Grider et al. 2015; Liuzzi 2014; Ryu et al. 2011). MTF-1 has been proposed as a master regulator for miRNA expression (Lee et al. 2007). The results of in silico studies from this laboratory support the hypothesis that genes within osteogenic signaling pathways are regulated by Zn mediated by MTF-1/MRE/miRNA interactions (Grider et al. 2017). The purpose of this investigation is to identify the locations of MREs upstream genes of miRNAs which then target genes within the TGF-β, MAPK, and Wnt signaling pathways. It must be noted, however, that previous results indicate that the presence of an MRE upstream from the transcriptional start site (TSS) of a gene does not necessitate its Zn-dependent or MTF-1 dependent regulation. The results presented here show that both miRNAs and their target genes contain MREs upstream from their TSSs, suggesting that the regulation of osteogenesis by Zn involves complex interactions between Zn, MRE/gene, and MRE/miRNA/gene associations. A model of feed-forward loops is proposed.
Materials and methods
All analyses were performed using the human hg38 genome assembly (Dec. 2017, Genome Reference Consortium GRCh38.p12). Bioconductor packages were run using R Studio (Huber et al. 2015; Team 2016). A summary of the workflow is shown in Fig. 1.
Positions of the MRE consensus sequence 5′-TGCRCNC-3′ in GRCh38.p12 were recorded using Biostrings (v2.48.0) (Pagès et al. 2018). BiomaRt (v2.36.0) was used to find the genomic coordinates of all HUGO Gene Nomenclature Committee (HGNC)-named genes (Durinck et al. 2005, 2009). Pre-miRNAs with TSSs predicted in human embryonic stem cells (hESC) by the microTSS algorithm (Georgakilas et al. 2014) were queried in the range of -7Kbp upstream and +1Kbp downstream, based on previous analysis, (Francis and Grider 2018) using GenomicRanges (v1.32.3) (Lawrence et al. 2013). microTSS genomic coordinates were batch converted from hg19 to hg38 using liftOver (Kent et al. 2002). Genes that were interrupted between their TSSs and nearest MRE were excluded from our analysis. The pre-miRNAs with proximal MREs were converted to their mature miRNA sequences using miRBase (Griffiths-Jones 2004; Griffiths-Jones et al. 2006, 2008; Kozomara and Griffiths-Jones 2011; Kozomara and Griffiths-Jones 2014). TarBase (experimentally verified) miRNA–target interactions (MTIs) between these mature miRNAs and genes were identified using miRTarBase via multiMiR (Database Version: 2.2.0 Updated: 2017-08-08) (Ru et al. 2014). These MTIs were sorted into their KEGG signaling pathways (Kanehisa et al. 2017); interactions in the TGF-β, MAPK, and Wnt pathways were chosen for further analysis. GenomicRanges was used to find genes in these pathways that have MRE sequences without interruption by other genes in their upstream -7Kbp region (Supplementary Table 1).
Venn diagrams (Oliveros 2007–2015) were produced from the lists of MTIs from each signaling pathway to identify those genes and miRNAs that are shared between pathways (Supplementary Table 2). The gene cohort with experimentally verified MTIs was analyzed by the Panther GO-Slim Biological Process (Panther Overrepresentation Test release 20171205; PANTHER version 13.1 Released 2018-02-02; α = 0.05) (Ashburner et al. 2000; Gene Ontology Consortium 2015; Tahimic et al. 2013; Zhao et al. 2017). In addition, genes from osteogenic KEGG pathways for which there was at least one experimentally verified MTI were subsequently used to query miRDB via multiMiR for predicted gene interactions (target scores ≥ 81) (Wang 2016; Wong and Wang 2015). The Panther Overrepresentation Test was performed on this cohort of predicted gene targets as well. Fisher’s exact testing with false discovery rate multiple test correction was used to identify significantly overrepresented annotated gene ontologies.
The experimentally verified MTI genes that are shared between the signaling pathways were analyzed for their protein–protein interactions using the STRING database (v10.5) (Szklarczyk et al. 2015, 2017). The interactions were visualized using the Network viewer. The analysis was performed using the highest minimum required interaction score (0.900). Only experimentally derived and database interaction sources are reported (Supplementary Table 3).
Results
The TSSs for 86 pre-miRNA genes were predicted by the microTSS algorithm; 44 of these pre-miRNAs contain an MRE within the range specified, without interruption between the MRE motif and the MIR gene TSS by the presence of another gene. These 44 pre-miRNAs equate to 73 mature miRNAs. Within the TGF-β, MAPK, and Wnt signaling pathways, 65 of the 73 mature miRNAs have Tarbase-verified MTIs (hereafter called “verified MTIs”) with 241 genes. Of the 460 genes in these three signaling pathways, 413 have an MRE in the range specified. Of those 413 genes, 213 have verified MTIs with 64 mature miRNAs which also have MREs. The TGF-β pathway contained MTIs consisting of 39 miRNAs/44 genes, the MAPK pathway contained MTIs consisting of 57 miRNAs/130 genes, and the Wnt pathway contained MTIs consisting of 43 miRNAs/61 genes. MAPK1 exhibited 10 MTIs, the most verified MTIs in the TGF-β and MAPK signaling pathways. CCND2 exhibited 9 MTIs, the most verified MTIs in the Wnt signaling pathway. Hsa-miR-124-3p targeted the most genes in the TGF-β (12 genes) and MAPK (32 genes) signaling pathways. Hsa-miR-20b-5p targeted the most genes, 12, in the Wnt signaling pathway (Table 1; Supplementary Table 1).
Genes with MREs and verified MTIs that are shared between two or more signaling pathways are organized in Venn diagrams (Fig. 2). MYC is the only gene that is shared among TGF-β, MAPK, and Wnt signaling pathways. MAPK and Wnt pathways share 11 other genes; TGF-β and MAPK pathways share five genes; and TGFβ and Wnt pathways share four genes (Fig. 2a; Supplementary Table 2). There are 28 miRNAs that are shared among the three pathways (Fig. 2b; Supplementary Table 2). There are seven miRNAs that are experimentally verified to target MYC (Table 2); hsa-miR-34a-5p exhibits the most MTIs within each signaling pathway. The seven miRNAs targeting MYC are within the cohort of 28 miRNAs that interact with all three pathways (Fig. 2b, c).
The protein–protein interactions of the genes shared between the three signaling pathways that are targets for miRNAs that contain MREs upstream from their TSSs, and that also contain MREs within their own promoter regions, were identified using the String database (v10.5) (Fig. 3; Supplementary Table 3). JUN exhibits the most protein–protein interactions (10), and MAPK8 exhibits the second most interactions (9). MYC, though involved with all three signaling pathways, interacts with just five other proteins.
There are 21 genes with verified MTIs that are common to at least two signaling pathways; these were used to query the Panther GO-Slim Biological Process database to identify overrepresented gene ontologies (Fig. 4). Intracellular signal transduction exhibited the highest enrichment score. This cohort is also significantly enriched in genes involved with cellular process, cell proliferation, and transmembrane receptor protein serine/threonine kinase signaling pathway. The 64 miRNAs with MREs that target genes in the osteogenic pathways exhibited 6886 predicted MTIs with 3613 genes (only target scores ≥ 81 were analyzed). This larger cohort of genes was enriched most in cellular process, followed by localization, metabolic process, and cell communication (data not shown).
Discussion
Zn is crucial for healthy bone growth and development, but the mechanism for its effects is complex and not fully elucidated. There is continued interest in understanding the translational control of osteogenesis through the nexus of miRNAs and osteogenic signaling pathway genes (Fushimi et al. 2018; Lian et al. 2012; Liu et al. 2018; Vimalraj and Selvamurugan 2013). Previous in silico analyses support the associations between Zn, MTF-1/MRE, and miRNAs in regulating osteogenic signaling pathways (Grider et al. 2017). This investigation serves to expand on the previous results, further supporting the role Zn plays in osteogenesis through its interaction with the MTF-1/MRE complex and miRNAs.
TGF-β, MAPK, and Wnt signaling pathways play key roles in osteogenesis (Baron and Kneissel 2013; Chen et al. 2012; Wu et al. 2016b). The data indicate that 213 genes within these three pathways have experimentally verified MTIs with 64 miRNAs. The MTIs in these pathways share a single gene, MYC, a proto-oncogene involved in cell cycle progression and transformation, and apoptosis. Others have shown that MYC expression is increased with activation of Wnt/β-catenin, and correlated with reduced terminal differentiation of osteoblasts, increased bone mass through osteoblast proliferation, and reduced bone strength (Chen et al. 2015; Li et al. 2017). The addition of EDTA to cultured HL-60 cells, a model of Zn deficiency, decreased the expression of MYC and cellular proliferation; Zn addition reversed these effects (Morimoto et al. 1992). Our data indicate that MYC contains several MREs in its promoter, supporting the hypothesis that Zn regulates MYC expression via MTF-1.
We also observed that seven miRNAs formed MTIs with MYC; these miRNAs also contain MREs upstream from their TSSs. Hsa-miR-34a-5p targets MYC and additionally exhibits the largest number of experimentally verified MTIs with this gene in each signaling pathway. The expression of this miRNA is induced in mice by dietary Zn (Liuzzi 2014). This miRNA has been studied extensively and inhibits osteoblast differentiation and bone formation. In models of human stromal (skeletal, mesenchymal) stem cell (hMSC) differentiation, overexpression of hsa-miR-34a in hMSCs reduced heterotopic bone formation by 60%. Conversely, in miR-34a-deficient hMSC, in vivo bone formation was increased by 200% (Chen et al. 2014). The available data indicate that osteoblast differentiation is inhibited by both MIR34A and MYC gene products. Others have found that the deletion of MYC in osteoclasts increases bone mass in mice which have undergone ovariectomy (Bae et al. 2017). The results from our in silico analysis suggests a complex relationship between the MRE, hsa-miR-34a-5p, and MYC effects on osteogenesis. MTF-1(Zn) activates gene expression via the MRE in both MYC and MIR34A; hsa-miR-34a-5p is expected to inhibit MYC but may act synergistically with the MRE in the MYC promoter to stimulate MYC transcription; the result is increased osteoblast proliferation, and decreased osteoblast differentiation and bone strength. These data suggest that the role of Zn in osteogenesis is a complex series of reactions between MTF-1/MRE, and genes in the signaling pathways that remain to be elucidated.
Genes that exhibit the most verified MTIs include MAPK1 and CCND2. MAPK1 exhibited the most MTIs within the TGF-β and MAPK signaling pathways. MAPK1 is a member of a serine/threonine kinase family of extracellular signal-regulated kinases that are involved in numerous phosphorylation reactions associated with development and cellular differentiation (Kyosseva 2004; Martin-Blanco 2000). It has also been reported to function as a transcriptional repressor (Hu et al. 2009). The interaction that MAPK1 and MYC exhibit may involve phosphorylation or transcriptional repression of MYC by MAPK1. CCND2 encodes cyclin D2, which complexes with cyclin-dependent kinases at the beginning of the G1 phase of the cell cycle (Sherr 1994; Vermeulen et al. 2003). CCND2 is not shared between Wnt and the other signaling pathways. Nevertheless, it is transcriptionally upregulated by the MYC gene product (Bouchard et al. 1999, 2001; Mai et al. 1999). CCND2 and MYC are also targeted by different sets of miRNAs.
The top five MTI miRNAs are the same among the three signaling pathways, though in different orders. Hsa-miR-124-3p is involved in the most MTIs in the TGF-β and MAPK signaling pathways. The downregulation of this miRNA is correlated with increased tumorigenesis and poor clinical outcomes, whereas upregulation results in decreased cell proliferation and tumor suppression (Feng et al. 2016; Yang et al. 2017; Zhang et al. 2015; Zhou et al. 2017). Hsa-miR-20b-5p is involved in the most MTIs in the Wnt signaling pathway. This miRNA also functions as a tumor suppressor (Xin et al. 2016) and is GO-linked to apoptosis and autophagy (Wu et al. 2016a). Our data support a role for Zn, through its binding to MTF-1 and subsequent MRE activation, in the transcriptional regulation of these miRNAs. Their specific effects on osteogenesis, though, remain to be determined.
MAPK8 and JUN exhibit the most protein–protein interactions among the MTI gene products shared between the TGF-β, MAPK, and Wnt signaling pathways. The JUN gene product, c-Jun, is activated by phosphorylation and is a necessary component of the AP-1 DNA-binding complex (Miller et al. 2010; Vasilevskaya and O’Dwyer 2003). c-Jun also forms a complex with β-catenin and TCF4 to upregulate MYC transcription at the 3′ enhancer region (Yochum et al. 2008). Our analysis indicates that several mitogen-activated protein kinases, also called c-Jun N-terminal kinases, are responsible for phosphorylating c-Jun, including the gene product of MAPK8, JNK1 (Bubici and Papa 2014). We report that JUN, MAPK8, and MYC are involved in MTIs, and each MTI component contains one or more MREs upstream from its TSS.
These observations support the hypothesis that the transcriptional regulation of osteogenesis by Zn occurs at multiple nodes within osteogenic signaling pathways. MREs are located upstream from the TSSs of both components of the MTI. We propose that feed-forward loops are involved with the Zn-dependent transcriptional regulation of osteogenesis through the MTF-1/MRE/MTI interactions (Fig. 5). The results from this study support the supposition that Zn regulation of bone growth and development occurs at the most fundamental levels. Future studies are planned to validate these complex Zn-dependent regulatory interactions as they relate to bone growth and development.
References
Andreini C, Banci L, Bertini I, Rosato A (2006) Counting the zinc-proteins encoded in the human genome. J Proteome Res 5:196–201. https://doi.org/10.1021/pr050361j
Arora S, Rana R, Chhabra A, Jaiswal A, Rani V (2013) miRNA–transcription factor interactions: a combinatorial regulation of gene expression. Mol Genet Genomics 288:77–87. https://doi.org/10.1007/s00438-013-0734-z
Ashburner M et al (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25:25–29. https://doi.org/10.1038/75556
Bae S, Lee MJ, Mun SH, Giannopoulou EG, Yong-Gonzalez V, Cross JR, Murata K, Giguere V, van der Meulen M, Park-Min KH (2017) MYC-dependent oxidative metabolism regulates osteoclastogenesis via nuclear receptor ERRα. J Clin Invest 127(7):2555–2568
Baron R, Kneissel M (2013) WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med 19:179–192. https://doi.org/10.1038/nm.3074
Berger PK et al (2015) Zinc supplementation increases procollagen type 1 amino-terminal propeptide in premenarcheal girls: a randomized controlled trial. J Nutr 145:2699–2704. https://doi.org/10.3945/jn.115.218792
Bittel DC, Smirnova IV, Andrews GK (2000) Functional heterogeneity in the zinc fingers of metalloregulatory protein metal response element-binding transcription factor-1. J Biol Chem 275:37194–37201. https://doi.org/10.1074/jbc.M003863200
Bouchard C, Thieke K, Maier A, Saffrich R, Hanley-Hyde J, Ansorge W, Reed S, Sicinski P, Bartek J, Eilers M (1999) Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J 18:5321–5333. https://doi.org/10.1093/emboj/18.19.5321
Bouchard C, Dittrich O, Kiermaier A, Dohmann K, Menkel A, Eilers M, Luscher B (2001) Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev 15:2042–2047. https://doi.org/10.1101/gad.907901
Bougle DL, Sabatier JP, Guaydier-Souquieres G, Guillon-Metz F, Laroche D, Jauzac P, Bureau F (2004) Zinc status and bone mineralisation in adolescent girls. J Trace Elem Med Biol 18:17–21. https://doi.org/10.1016/j.jtemb.2004.03.001
Bubici C, Papa S (2014) JNK signalling in cancer: in need of new, smarter therapeutic targets. Br J Pharmacol 171:24–37. https://doi.org/10.1111/bph.12432
Cesur Y, Yordam N, Dogan M (2009) Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels in children with zinc deficiency and the effect of zinc supplementation on these parameters. J Pediatr Endocrinol Metab 22:1137–1143
Chen XH, Agarwal A, Giedroc DP (1998) Structural and functional heterogeneity among the zinc fingers of human MRE-binding transcription factor-1. Biochemistry 37:11152–11161
Chen X, Chu M, Giedroc DP (1999) MRE-Binding transcription factor-1: weak zinc-binding finger domains 5 and 6 modulate the structure, affinity, and specificity of the metal-response element complex. Biochem 38:12915–12925
Chen G, Deng C, Li YP (2012) TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 8:272–288. https://doi.org/10.7150/ijbs.2929
Chen L, Holmstrom K, Qiu W, Ditzel N, Shi K, Hokland L, Kassem M (2014) MicroRNA-34a inhibits osteoblast differentiation and in vivo bone formation of human stromal stem cells. Stem Cells 32:902–912. https://doi.org/10.1002/stem.1615
Chen S et al (2015) Adverse effects of osteocytic constitutive activation of ss-catenin on bone strength and bone growth. J Bone Miner Res 30:1184–1194. https://doi.org/10.1002/jbmr.2453
Cho YE, Lomeda RA, Ryu SH, Sohn HY, Shin HI, Beattie JH, Kwun IS (2007) Zinc deficiency negatively affects alkaline phosphatase and the concentration of Ca, Mg and P in rats. Nutr Res Pract 1:113–119. https://doi.org/10.4162/nrp.2007.1.2.113
Chu Y, Mouat MF, Harris RB, Coffield JA, Grider A (2003) Water maze performance and changes in serum corticosterone levels in zinc-deprived and pair-fed rats. Physiol Behav 78:569–578
Durinck SMY, Kasprzyk A, Davis S, De Moor B, Brazma A, Huber W (2005) BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis. Bioinformatics 21:3439–3440
Durinck SSP, Birney E, Huber W (2009) Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt. Nat Protoc 4:1184–1191
Eiring AM et al (2010) miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell 140:652–665
Feng T et al (2016) miR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4/E2F1 signal activation. Oncotarget 7:16205–16216. https://doi.org/10.18632/oncotarget.7578
Francis M, Grider A (2018) Bioinformatic analysis of the metal response element and zinc-dependent gene regulation via the metal response element-binding transcription factor 1 in Caco-2 cells. Biometals. https://doi.org/10.1007/s10534-018-0115-5
Fushimi S, Nohno T, Nagatsuka H, Katsuyama H (2018) Involvement of miR-140-3p in Wnt3a and TGFbeta3 signaling pathways during osteoblast differentiation in MC3T3-E1 cells. Genes Cells 23:517–527. https://doi.org/10.1111/gtc.12591
Gene Ontology Consortium (2015) Gene Ontology Consortium: going forward. Nucleic Acids Res 43:1049–1056. https://doi.org/10.1093/nar/gku1179
Georgakilas G, Vlachos IS, Paraskevopoulou MD, Yang P, Zhang Y, Economides AN, Hatzigeorgiou AG (2014) microTSS: accurate microRNA transcription start site identification reveals a significant number of divergent pri-miRNAs. Nat Commun 5:5700. https://doi.org/10.1038/ncomms6700
Grider A, Mouat MF, Scrimgeour AG (2007) Consumption of a moderately Zn-deficient and Zn-supplemented diet affects soluble protein expression in rat soleus muscle. J Nutr Biochem 18:753–759. https://doi.org/10.1016/j.jnutbio.2006.11.013
Grider A, Lewis RD, Laing EM, Bakre AA, Tripp RA (2015) Zinc affects miR-548n, SMAD4, SMAD5 expression in HepG2 hepatocyte and HEp-2 lung cell lines. Biometals 28:959–966. https://doi.org/10.1007/s10534-015-9880-6
Grider A, Bakre AA, Laing EM, Lewis RD (2017) In silico analysis of MicroRNA regulation of bone development: metal response element-binding transcription factor 1 and bone signaling pathways. Austin J Nutr Metab 4:1042
Griffiths-Jones S (2004) The microRNA Registry. Nucleic Acids Res 32:D109–D111. https://doi.org/10.1093/nar/gkh023
Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34:D140–D144. https://doi.org/10.1093/nar/gkj112
Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36:D154–D158. https://doi.org/10.1093/nar/gkm952
Guerrerio AL, Berg JM (2004) Metal ion affinities of the zinc finger domains of the metal responsive element-binding transcription factor-1 (MTF1). Biochem 43:5437–5444. https://doi.org/10.1021/bi0358418
Guntur AR, Rosen CJ (2013) IGF-1 regulation of key signaling pathways in bone. Bonekey Rep 2:437. https://doi.org/10.1038/bonekey.2013.171
Hambidge KM, Krebs NF (2007) Zinc deficiency: a special challenge. J Nutr 137:1101–1105
Hamza RT, Hamed AI, Sallam MT (2012) Effect of zinc supplementation on growth Hormone Insulin growth factor axis in short Egyptian children with zinc deficiency. Ital J Pediatr. https://doi.org/10.1186/1824-7288-38-21
Hess SY, Lonnerdal B, Hotz C, Rivera JA, Brown KH (2009) Recent advances in knowledge of zinc nutrition and human health. Food Nutr Bull 30:S5–11. https://doi.org/10.1177/15648265090301S102
Hu S et al (2009) Profiling the human protein-DNA interactome reveals ERK2 as a transcriptional repressor of interferon signaling. Cell 139:610–622. https://doi.org/10.1016/j.cell.2009.08.037
Huber W et al (2015) Orchestrating high-throughput genomic analysis with Bioconductor. Nat Methods 12:115. https://doi.org/10.1038/nmeth.3252
Igarashi A, Yamaguchi M (2001) Increase in bone growth factors with healing rat fractures: the enhancing effect of zinc. Int J Mol Med 8:433–438
Imamoglu S, Bereket A, Turan S, Haklar G (2005) Effect of zinc supplementation on growth hormone secretion, IGF-I, IGFBP-3, somatomedin generation, alkaline phosphatase, osteocalcin and growth in prepubertal children with idiopathic short stature. J Pediatr Endocrinol Metab 18:69–74
International Zinc Nutrition Consultative Group et al. (2004) International Zinc Nutrition Consultative Group (IZiNCG) technical document #1. Assessment of the risk of zinc deficiency in populations and options for its control. Food Nutr Bull 25:S99–S203
Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K (2017) KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 45:D353–D361. https://doi.org/10.1093/nar/gkw1092
Keller KA, Chu Y, Grider A, Coffield JA (2000) Supplementation with l-histidine during dietary zinc repletion improves short-term memory in zinc-restricted young adult male rats. J Nutr 130:1633–1640
Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D (2002) The human genome browser at UCSC. Genome Res 12:996–1006
Klug A (2010) The discovery of zinc fingers and their applications in gene regulation and genome manipulation. Annu Rev Biochem 79:213–231. https://doi.org/10.1146/annurev-biochem-010909-095056
Kozomara A, Griffiths-Jones S (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39:D152–D157. https://doi.org/10.1093/nar/gkq1027
Kozomara A, Griffiths-Jones S (2014) miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 42:D68–D73. https://doi.org/10.1093/nar/gkt1181
Kyosseva SV (2004) Mitogen-activated protein kinase signaling. Int Rev Neurobiol 59:201–220. https://doi.org/10.1016/S0074-7742(04)59008-6
Langmade SJ, Ravindra R, Daniels PJ, Andrews GK (2000) The transcription factor MTF-1 mediates metal regulation of the mouse ZnT1 gene. J Biol Chem 275:34803–34809
Lawrence MHW, Pagès H, Aboyoun P, Carlson M, Gentleman R, Morgan M, Carey V (2013) Software for computing and annotating genomic ranges. PLoS Comput Biol. https://doi.org/10.1371/journal.pcbi.1003118
Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843–854. https://doi.org/10.1016/0092-8674(93)90529-Y
Lee J, Li Z, Brower-Sinning R, John B (2007) Regulatory circuit of human microRNA biogenesis. PLoS Comput Biol 3:e67. https://doi.org/10.1371/journal.pcbi.0030067
Li JF et al (2017) Different bone remodeling levels of trabecular and cortical bone in response to changes in Wnt/beta-catenin signaling in mice. J Orthop Res 35:812–819. https://doi.org/10.1002/jor.23339
Lian JB, Stein GS, van Wijnen AJ, Stein JL, Hassan MQ, Gaur T, Zhang Y (2012) MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol 8:212–227. https://doi.org/10.1038/nrendo.2011.234
Liu GX et al (2018) Hsa-let-7c controls the committed differentiation of IGF-1-treated mesenchymal stem cells derived from dental pulps by targeting IGF-1R via the MAPK pathways. Exp Mol Med 50:25. https://doi.org/10.1038/s12276-018-0048-7
Liuzzi JP (2014) Up-regulation of miR-34a by zinc deficiency. Vitam Miner 3:119. https://doi.org/10.4172/vms.1000119
Longobardi L et al (2006) Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J Bone Miner Res 21:626–636. https://doi.org/10.1359/jbmr.051213
Mai S et al (1999) Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression. Neoplasia 1:241–252
Martin-Blanco E (2000) p38 MAPK signalling cascades: ancient roles and new functions. BioEssays 22:637–645
McCusker RH (1998) Controlling insulin-like growth factor activity and the modulation of insulin-like growth factor binding protein and receptor binding. J Dairy Sci 81:1790–1800. https://doi.org/10.3168/jds.S0022-0302(98)75748-0
McCusker RH, Kaleko M, Sackett RL (1998) Multivalent cations and ligand affinity of the type 1 insulin-like growth factor receptor on P2A2-LISN muscle cells. J Cell Physiol 176:392–401
Miller GM, Ogunnaike BA, Schwaber JS, Vadigepalli R (2010) Robust dynamic balance of AP-1 transcription factors in a neuronal gene regulatory network. BMC Syst Biol 4:171. https://doi.org/10.1186/1752-0509-4-171
Morimoto S et al (1992) EDTA induces differentiation and suppresses proliferation of promyelocytic leukemia cell line HL-60—possible participation of zinc. Biochem Int 28:313–321
O’Halloran T (1993) Transition metals in control of gene expression. Science 261:715–725. https://doi.org/10.1126/science.8342038
Oliveros JC (2007–2015) Venny. An interactive tool for comparing lists with Venn’s diagrams. http://bioinfogp.cnb.csic.es/tools/venny/index.html. Accessed 01 Aug 2018
Orom UA, Nielsen FC, Lund AH (2008) MicroRNA-10a binds the 5 ‘ UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 30:460–471
Pagès H AP, Gentleman R, DebRoy S (2018) Biostrings: Efficient manipulation of biological strings. R package version 2.48.0
Park SG, Choi HN, Yang HR, Yim JE (2017) Effects of zinc supplementation on catch-up growth in children with failure to thrive. Nutr Res Pract 11:487–491. https://doi.org/10.4162/nrp.2017.11.6.487
Ru Y et al (2014) The multiMiR R package and database: integration of microRNA–target interactions along with their disease and drug associations. Nucleic Acids Res 42:e133–e133. https://doi.org/10.1093/nar/gku631
Ryu MS, Langkamp-Henken B, Chang SM, Shankar MN, Cousins RJ (2011) Genomic analysis, cytokine expression, and microRNA profiling reveal biomarkers of human dietary zinc depletion and homeostasis. Proc Natl Acad Sci USA 108:20970–20975. https://doi.org/10.1073/pnas.1117207108
Sackett RL, McCusker RH (1998a) Multivalent cations depress ligand affinity of insulin-like growth factor-binding proteins-3 and -5 on human GM-10 fibroblast cell surfaces. J Cell Biochem 69:364–375
Sackett RL, McCusker RH (1998b) Multivalent cations depress ligand binding to cell-associated insulin-like growth factor binding protein-5 on human glioblastoma cells. Endocrinology 139:1943–1951. https://doi.org/10.1210/endo.139.4.5924
Saydam N, Adams TK, Steiner F, Schaffner W, Freedman JH (2002) Regulation of metallothionein transcription by the metal-responsive transcription factor MTF-1—identification of signal transduction cascades that control metal-inducible transcription. J Biol Chem 277:20438–20445. https://doi.org/10.1074/jbc.M110631200
Seo HJ, Cho YE, Kim T, Shin HI, Kwun IS (2010) Zinc may increase bone formation through stimulating cell proliferation, alkaline phosphatase activity and collagen synthesis in osteoblastic MC3T3-E1 cells. Nutr Res Pract 4:356–361. https://doi.org/10.4162/nrp.2010.4.5.356
Sherr CJ (1994) G1 phase progression: cycling on cue. Cell 79:551–555
Stuart GW, Searle PF, Chem HY, Brinster RL, Palmiter RD (1984) A 12-base-pair DNA motif that is repeated several times in metallothionein gene promoters confers metal regulation to a heterologous gene. Proc Natl Acad Sci USA 81:7318–7322
Szklarczyk D et al (2015) STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res 43:D447–D452. https://doi.org/10.1093/nar/gku1003
Szklarczyk D et al (2017) The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res 45:D362–D368
Tahimic CG, Wang Y, Bikle DD (2013) Anabolic effects of IGF-1 signaling on the skeleton. Front Endocrinol 4:6. https://doi.org/10.3389/fendo.2013.00006
Team R (2016) RStudio: integrated development for R. RStudio, Inc., Boston. http://www.rstudio.com/
Tuerk MJ, Fazel N (2009) Zinc deficiency. Curr Opin Gastroenterol 25:136–143. https://doi.org/10.1097/Mog.0b013e328321b395
Vasilevskaya I, O’Dwyer PJ (2003) Role of Jun and Jun kinase in resistance of cancer cells to therapy. Drug Resist Updat 6:147–156
Vasudevan S, Tong YC, Steitz JA (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science 318:1931–1934
Vermeulen K, Van Bockstaele DR, Berneman ZN (2003) The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36:131–149
Vimalraj S, Selvamurugan N (2013) MicroRNAs: synthesis, gene regulation and osteoblast differentiation. Curr Issues Mol Biol 15:7–18
Wang X (2016) Improving microRNA target prediction by modeling with unambiguously identified microRNA-target pairs from CLIP-ligation studies. Bioinformatics 32:1316–1322. https://doi.org/10.1093/bioinformatics/btw002
Wong N, Wang X (2015) miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res 43:D146–D152. https://doi.org/10.1093/nar/gku1104
Wu BL et al (2016a) An integrative framework to identify cell death-related microRNAs in esophageal squamous cell carcinoma. Oncotarget 7:56758–56766
Wu M, Chen G, Li YP (2016b) TGF-beta and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res 4:16009. https://doi.org/10.1038/boneres.2016.9
Wuehler SE, Peerson JM, Brown KH (2005) Use of national food balance data to estimate the adequacy of zinc in national food supplies: methodology and regional estimates. Public Health Nutr 8:812–819. https://doi.org/10.1079/Phn2005724
Xin Y, Cai H, Lu T, Zhang Y, Yang Y, Cui Y (2016) miR-20b inhibits T Cell proliferation and activation via NFAT signaling pathway in thymoma-associated Myasthenia Gravis. Biomed Res Int 2016:9595718. https://doi.org/10.1155/2016/9595718
Yang Y et al (2017) MicroRNA214 targets Wnt3a to suppress liver cancer cell proliferation. Mol Med Rep 16:6920–6927. https://doi.org/10.3892/mmr.2017.7483
Yochum GS, Cleland R, Goodman RH (2008) A genome-wide screen for beta-catenin binding sites identifies a downstream enhancer element that controls c-Myc gene expression. Mol Cell Biol 28:7368–7379
Zhang Y, Li H, Han J, Zhang Y (2015) Down-regulation of microRNA-124 is correlated with tumor metastasis and poor prognosis in patients with lung cancer. Int J Clin Exp Pathol 8:1967–1972
Zhao Y, Wang F, Chen S, Wan J, Wang G (2017) Methods of MicroRNA promoter prediction and transcription factor mediated regulatory network. Biomed Res Int 2017:8. https://doi.org/10.1155/2017/7049406
Zhou Y, Han Y, Zhang Z, Shi Z, Zhou L, Liu X, Jia X (2017) MicroRNA-124 upregulation inhibits proliferation and invasion of osteosarcoma cells by targeting sphingosine kinase 1. Hum Cell 30:30–40. https://doi.org/10.1007/s13577-016-0148-4
Acknowledgments
This research was partially funded by the University of Georgia Experiment Station Hatch Funds (to AG).
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Francis, M., Grider, A. MiRNA–target interactions in osteogenic signaling pathways involving zinc via the metal regulatory element. Biometals 32, 111–121 (2019). https://doi.org/10.1007/s10534-018-00162-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10534-018-00162-4